Steven Staelens Selected Research

Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)

1/2019

18F-Flortanidazole Hypoxia PET Holds Promise as a Prognostic and Predictive Imaging Biomarker in a Lung Cancer Xenograft Model Treated with Metformin and Radiotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Steven Staelens Research Topics

Disease

23	Neoplasms (Cancer) 01/2021 - 04/2010
11	Colorectal Neoplasms (Colorectal Cancer) 07/2020 - 11/2011
9	Alzheimer Disease (Alzheimer's Disease) 12/2023 - 01/2015
9	Huntington Disease (Huntington's Disease) 12/2023 - 01/2018
6	Epilepsy (Aura) 12/2023 - 11/2013
6	Nervous System Diseases (Neurological Disorders) 01/2021 - 05/2010
5	Amyloidosis 01/2017 - 01/2015
4	Neurodegenerative Diseases (Neurodegenerative Disease) 10/2023 - 04/2020
4	Disease Progression 01/2022 - 01/2019
4	Neuroinflammatory Diseases 01/2021 - 02/2016
4	Status Epilepticus (Complex Partial Status Epilepticus) 01/2021 - 10/2015
4	Inflammation (Inflammations) 01/2019 - 04/2013
3	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 10/2020 - 11/2016
3	Hypoxia (Hypoxemia) 08/2019 - 01/2016
3	Neoplasm Metastasis (Metastasis) 01/2017 - 07/2014
2	Breast Neoplasms (Breast Cancer) 02/2023 - 07/2014
2	Dementia (Dementias) 01/2019 - 01/2017
2	Cognitive Dysfunction 01/2019 - 01/2017
2	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2019 - 01/2017
2	Temporal Lobe Epilepsy 01/2017 - 10/2015
2	Seizures (Absence Seizure) 01/2017 - 08/2013
2	Schizophrenia (Dementia Praecox) 02/2016 - 11/2013
2	Body Weight (Weight, Body) 01/2016 - 11/2011
2	Aneurysm (Aneurysms) 01/2014 - 09/2011
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 12/2023
1	Intellectual Disability (Idiocy) 12/2023
1	Autism Spectrum Disorder 12/2023
1	Contusions 01/2022
1	Chronic Disease (Chronic Diseases) 01/2021
1	Atherosclerosis 05/2020
1	Atherosclerotic Plaque (Atheroma) 05/2020
1	Unilateral Hearing Loss 01/2020
1	Brain Diseases (Brain Disorder) 01/2020
1	Tinnitus 01/2020
1	Autistic Disorder (Autism) 01/2019
1	Psychotic Disorders (Schizoaffective Disorder) 01/2019
1	Lung Neoplasms (Lung Cancer) 01/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019

Drug/Important Bio-Agent (IBA)

20	Biomarkers (Surrogate Marker)IBA 12/2023 - 07/2014
10	Proteins (Proteins, Gene)FDA Link 01/2022 - 08/2011
9	Amyloid (Amyloid Fibrils)IBA 01/2019 - 01/2015
6	Caspase 3 (Caspase-3)IBA 01/2019 - 04/2012
6	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 11/2011
6	Glucose (Dextrose)FDA LinkGeneric 04/2016 - 01/2014
5	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 02/2023 - 04/2017
4	Glycoproteins (Glycoprotein)IBA 10/2022 - 01/2020
4	2- (6- chloro- 2- (4- (3- fluoropropoxy)phenyl)imidazo(1,2- a)pyridin- 3- yl)- N,N- diethylacetamideIBA 01/2021 - 03/2017
4	Glutamic Acid (Glutamate)FDA Link 04/2020 - 11/2013
4	micaIBA 03/2020 - 01/2017
3	Kainic Acid (Kainate)IBA 01/2021 - 10/2015
3	Metabotropic Glutamate 5 ReceptorIBA 10/2020 - 01/2018
3	Monoclonal AntibodiesIBA 03/2020 - 04/2010
3	technetium 99m HYNIC-duramycinIBA 01/2018 - 01/2016
3	duramycinIBA 01/2018 - 12/2015
3	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2017 - 07/2014
3	2- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA 12/2015 - 10/2015
2	Huntingtin ProteinIBA 12/2023 - 10/2023
2	polyglutamineIBA 10/2023 - 01/2022
2	alovudineIBA 02/2023 - 01/2017
2	1- ((3- (methylpyridin- 4- yl)methyl)- 4- (3,4,5- trifluorophenyl)pyrrolidin- 2- oneIBA 01/2022 - 01/2022
2	LigandsIBA 01/2022 - 01/2018
2	Serine Proteases (Serine Protease)IBA 07/2020 - 01/2017
2	EnzymesIBA 05/2020 - 05/2010
2	Apolipoproteins E (ApoE)IBA 05/2020 - 09/2011
2	Radioisotopes (Radionuclides)IBA 03/2020 - 04/2010
2	Metformin (Glucophage)FDA LinkGeneric 08/2019 - 01/2019
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2019 - 05/2010
2	conatumumabIBA 01/2018 - 04/2017
2	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 01/2016
2	Gemcitabine FDA Link 11/2016 - 04/2016
2	Plasminogen Activator Inhibitor 1IBA 11/2016 - 07/2014
2	4- (N- methylamino)- 4'- (2- (2- (2- fluoroethoxy)ethoxy)ethoxy)stilbeneIBA 12/2015 - 10/2015
2	Annexin A5IBA 04/2012 - 11/2011
2	Bevacizumab (Avastin)FDA Link 04/2012 - 11/2011
1	pyrimidineIBA 12/2023
1	TOR Serine-Threonine KinasesIBA 02/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2023
1	Dopamine (Intropin)FDA LinkGeneric 01/2021
1	Trastuzumab (Herceptin)FDA Link 01/2021
1	Everolimus FDA Link 01/2021
1	PK 11195 (PK11195)IBA 01/2021
1	SCH 23390IBA 01/2021
1	3- (6- methylpyridin- 2- ylethynyl)cyclohex- 2- enone- O- methyloximeIBA 10/2020
1	Proline (L-Proline)FDA Link 07/2020
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 07/2020
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 04/2020
1	CyclooctanesIBA 03/2020
1	3- fluoro- 2- (4- ((2- nitro- 1H- imidazol- 1- yl)methyl)- 1H- 1,2,3- triazol- 1- yl)propan- 1- olIBA 08/2019
1	Therapeutic UsesIBA 08/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2019
1	Phosphoric Diester Hydrolases (Phosphodiesterases)IBA 01/2018
1	GABA-A Receptors (GABA(A) Receptor)IBA 12/2017

Therapy/Procedure

14	Therapeutics 02/2023 - 04/2010
5	Drug Therapy (Chemotherapy) 01/2018 - 07/2011
4	Radiotherapy 08/2019 - 01/2016
3	Secondary Prevention 04/2017 - 01/2017
2	Cochlear Implants (Cochlear Implant) 01/2020 - 12/2014
2	Aftercare (After-Treatment) 04/2017 - 11/2011
2	Transcranial Magnetic Stimulation 01/2017 - 07/2013
1	Auditory Brain Stem Implants (Auditory Brainstem Implants) 01/2020